-
AMPK, ULK1, and Energy Stress in Autophagy
2026-08-12
The reference study challenges the prevailing view that AMPK universally activates autophagy during glucose deprivation. Its cell-based evidence shows that AMPK suppresses ULK1 initiation signaling during acute energy stress while protecting the autophagy machinery from caspase-mediated loss, thereby separating short-term restraint from later recovery.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Guide
2026-08-11
Learn how ARCA Cy5 EGFP mRNA (5-moUTP), SKU R1009, helps separate delivery, translation, and cell-health effects in mammalian assays. This scenario-based guide covers experimental design, handling, interpretation, and practical product selection for reproducible mRNA delivery studies.
-
2X Taq PCR Master Mix for SPVD Assays
2026-08-11
Learn how 2X Taq PCR Master Mix (with dye) can complement image-based sweetpotato virus disease screening. This article connects deep-learning lesion segmentation with practical PCR confirmation, assay controls, and TA-cloning decisions.
-
Circular RNA Neoantigen Vaccines for HCC
2026-08-10
The reference study develops a circular RNA vaccine encoding hepatocellular carcinoma neoantigens and links RNA circularization with sustained expression, dendritic-cell activation, and antitumor T-cell responses. Its lipid nanoparticle delivery strategy produced therapeutic and preventive activity in murine tumor models, while also highlighting the experimental steps needed before translation to personalized cancer immunotherapy.
-
Cyclosporin A: From Pathway to Translation
2026-08-09
Cyclosporin A is more than a calcineurin inhibitor: it is a mechanistic probe linking cyclophilin biology, T-cell regulation, and mitochondrial membrane integrity. This translational guide shows how to design better experiments, interpret congener differences, and use Cyclosporin strategically across immunology and mitochondrial research.
-
Autophagy and Resveratrol Apoptosis in RCC
2026-08-08
The reference study shows that resveratrol induces ROS-associated mitochondrial injury and caspase-3-dependent apoptosis in renal cell carcinoma 786-O cells, while JNK-linked autophagy functions as a protective response. Its inhibitor and gene-silencing experiments suggest that combining resveratrol with autophagy suppression may intensify tumor-cell killing, although the evidence remains limited to an in vitro model.
-
Nilotinib (AMN-107): From BCR-ABL to Biology
2026-08-07
Nilotinib (AMN-107) is best known as a selective BCR-ABL inhibitor for chronic myeloid leukemia research, but its activity across c-Abl, KIT, and PDGFR-linked signaling also makes it a valuable translational probe. This article connects cancer pharmacology with neurodegeneration research while emphasizing assay controls, exposure design, and the limitations revealed by recent Alzheimer’s disease data.
-
Parthenolide-Induced ROS Apoptosis in Lymphoid Malignancies
2026-08-07
Jorge et al. (2023) demonstrate that parthenolide induces apoptosis via reactive oxygen species (ROS) in B- and T-lymphoid malignancy cell lines, with variable sensitivity across disease subtypes. This work clarifies the mechanistic role of redox modulation in parthenolide's anticancer effects and supports its potential as a targeted therapeutic strategy.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode Tracking in mR
2026-08-06
EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) offers unmatched precision for tracking mRNA delivery and protein expression through combined fluorescence and bioluminescence modalities. This innovative reagent empowers researchers to streamline transfection optimization, real-time intracellular tracking, and immune evasion studies with data-driven confidence.
-
Low-Affinity Blockade of N-Type Ca Channels by ω-Agatoxin IV
2026-08-06
Sidach and Mintz’s study clarifies the pharmacological specificity of ω-Agatoxin IVA, demonstrating its high-affinity block of P-type calcium channels and unexpectedly low-affinity, partial block of N-type channels in mammalian neurons. These insights refine the interpretation of Cav2.1 channel targeting in neuronal current recordings and inform the selective use of spider toxins in synaptic transmission research.
-
Synergistic Antitumor Immunity via Radiotherapy and Dual Che
2026-08-05
This study demonstrates that combining radiotherapy with PD-1 and TIGIT blockade produces robust antitumor abscopal effects and long-term immune memory, mediated by CD8+ T cells. The findings clarify mechanisms underlying immune resistance and highlight the importance of M1 macrophage polarization and NF-κB signaling in therapeutic synergy.
-
Phosphatase Inhibitor Cocktail 3: Precision in Ferroptosis R
2026-08-05
Explore how Phosphatase Inhibitor Cocktail 3 (100X in DMSO) enables reliable protein phosphorylation preservation for cutting-edge ferroptosis studies. This article uniquely bridges mechanistic insight from mitochondrial DNA release to practical assay design.
-
Anti Reverse Cap Analog (ARCA): Precision mRNA Capping for E
2026-08-04
Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, enables orientation-specific capping of synthetic mRNAs, doubling translational efficiency compared to conventional cap analogs. This mechanism is essential for robust protein expression in mRNA therapeutics and cell reprogramming workflows.
-
Oridonin Suppresses Esophageal Cancer via TLR4/NF-κB/NLRP3 A
2026-08-04
Peng et al. (2025) demonstrate that oridonin effectively inhibits esophageal cancer progression in a murine model by targeting the TLR4/NF-κB/NLRP3 inflammasome pathway. This study advances understanding of inflammation-driven tumorigenesis and highlights anti-inflammatory targeting as a promising strategy for esophageal cancer intervention.
-
Pioglitazone: PPARγ Agonist Workflows in Inflammation Models
2026-08-03
Leverage Pioglitazone as a selective PPARγ agonist for advanced inflammation and metabolic disease research. This guide provides actionable workflow enhancements, protocol parameters, and troubleshooting rooted in the latest STAT-1/STAT-6 pathway findings.